University College London School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, UK.
Department of Mechanical Engineering, University College London, Torrington Place, London WC1E 7JE, UK.
Nanoscale. 2017 May 11;9(18):5975-5985. doi: 10.1039/c7nr01002h.
This study outlines a novel manufacturing technique for the generation of compartmentalized trilayered nanoparticles loaded with an anti-cancer agent and siRNA as a platform for the combination treatment of cancers. More specifically, we describe the use of a multi-needle electrohydrodynamic approach to produce nanoparticles with high size specificity and scalable output, while allowing suitable environments for each therapeutic agent. The inner polylactic-glycolic-acid (PLGA) layer was loaded with cisplatin while the middle chitosan layer was loaded with siRNA. The corresponding polymeric solutions were characterized for their viscosity, surface tension and conductivity, while particle size was determined using dynamic light scattering. The internal structure was studied using transmission electron microscopy (TEM) and Structured Illumination Microscopy (SIM). The inclusion of cisplatin was studied using electron dispersive spectroscopy (EDS). We were able to generate nanoparticles of approximate size 130 nm with three distinct layers containing an outer protective PLGA layer, a middle layer of siRNA and an inner layer of cisplatin. These particles have the potential not only for uptake into tumors via the enhanced permeability and retention (EPR) effect but also the sequential release of the siRNA and chemotherapeutic agent, thereby providing a means of overcoming challenges of targeting and tumor drug resistance.
本研究概述了一种用于生成载有抗癌剂和 siRNA 的分区三层纳米粒子的新型制造技术,作为癌症联合治疗的平台。更具体地说,我们描述了使用多针电动力学方法来生产具有高尺寸特异性和可扩展输出的纳米粒子,同时为每个治疗剂提供合适的环境。内层聚乳酸-羟基乙酸共聚物(PLGA)层装载顺铂,而中间壳聚糖层装载 siRNA。使用动态光散射法测定了相应的聚合物溶液的粘度、表面张力和电导率,而粒径则使用动态光散射法测定。使用透射电子显微镜(TEM)和结构光照明显微镜(SIM)研究内部结构。使用电子分散光谱法(EDS)研究了顺铂的包含情况。我们能够生成大约 130nm 大小的具有三个不同层的纳米粒子,包含外层保护层聚乳酸-羟基乙酸共聚物(PLGA)、中间层 siRNA 和内层顺铂。这些粒子不仅有可能通过增强的通透性和保留(EPR)效应被肿瘤吸收,而且还可以顺序释放 siRNA 和化疗药物,从而提供了一种克服靶向和肿瘤耐药性挑战的方法。